NYSE:EW
Edwards Lifesciences Corporation
- Stock
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Lippis Daniel J. CVP, JAPAC Common Stock | 2024-04-09 | 0 0% |
Lemercier Jean-Luc M CVP, EMEACLA Common Stock | 2024-04-08 | 0 0% |
Bobo Donald E Jr CVP,Strategy/Corp Development Common Stock | 2024-04-08 | 0 0% |
Mussallem Michael A Director Common Stock | 2024-04-04 | 0 0% |
Ullem Scott B. CVP, Chief Financial Officer Common Stock | 2024-04-01 | 0 0% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Mussallem Michael A Chairman & CEO Common Stock | 2023-05-11 | 3.56M 5,834.46% |
Mussallem Michael A Chairman & CEO Common Stock | 2023-04-17 | 3.55M 5,818.87% |
Mussallem Michael A Chairman & CEO Common Stock | 2023-03-14 | 3.44M 2,186.53% |
Mussallem Michael A Chairman & CEO Common Stock | 2022-05-10 | 3.31M 3,288.83% |
Mussallem Michael A Chairman & CEO Common Stock | 2022-03-22 | 3.30M 4,165.72% |
Transaction Log
| Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
|---|---|---|---|---|---|---|---|---|
2024-04-09 | 2024-04-09 | Lippis Daniel J. | CVP, JAPAC | 17.49K | 857 | S | Common Stock | -79.14K |
2024-04-09 | 2024-04-09 | Lippis Daniel J. | CVP, JAPAC | 18.34K | 857 | M | Common Stock | 31.49K |
2024-04-08 | 2024-04-08 | Lemercier Jean-Luc M | CVP, EMEACLA | 188.14K | 107 | S | Common Stock | -9.91K |
2024-04-08 | 2024-04-08 | Lemercier Jean-Luc M | CVP, EMEACLA | 188.25K | 14.40K | M | Common Stock | 529.20K |
2024-04-08 | 2024-04-08 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.77K | 12.40K | S | Common Stock | -1.14M |
2024-04-08 | 2024-04-08 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 52.17K | 100 | S | Common Stock | -9.27K |
2024-04-08 | 2024-04-08 | Lemercier Jean-Luc M | CVP, EMEACLA | 173.85K | 14.29K | S | Common Stock | -1.32M |
2024-04-08 | 2024-04-08 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 52.27K | 12.50K | M | Common Stock | 459.38K |
2024-04-04 | 2024-04-04 | Mussallem Michael A | Director | 30.92K | 2.71K | S | Common Stock | -254.17K |
2024-04-04 | 2024-04-04 | Mussallem Michael A | Director | 4.49K | 16.62K | S | Common Stock | -1.54M |
2024-04-04 | 2024-04-04 | Mussallem Michael A | Director | 33.64K | 200 | S | Common Stock | -18.84K |
2024-04-04 | 2024-04-04 | Mussallem Michael A | Director | 21.10K | 9.82K | S | Common Stock | -898.92K |
2024-04-04 | 2024-04-04 | Mussallem Michael A | Director | 33.84K | 29.35K | M | Common Stock | 1.08M |
2024-04-01 | 2024-04-01 | Ullem Scott B. | CVP, Chief Financial Officer | 25.46K | 868 | S | Common Stock | -82.90K |
2024-04-01 | 2024-04-01 | Ullem Scott B. | CVP, Chief Financial Officer | 26.33K | 7.25K | M | Common Stock | 266.62K |
2024-04-01 | 2024-04-01 | Ullem Scott B. | CVP, Chief Financial Officer | 19.07K | 6.39K | S | Common Stock | -605.52K |
2024-03-13 | 2024-03-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 54.00K | 14.50K | M | Common Stock | 532.88K |
2024-03-13 | 2024-03-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 14.50K | S | Common Stock | -1.32M |
2024-03-11 | 2024-03-11 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 187.98K | 14.40K | M | Common Stock | 529.20K |
2024-03-11 | 2024-03-11 | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 173.58K | 14.40K | S | Common Stock | -1.32M |
2024-03-04 | 2024-03-04 | Mussallem Michael A | Director | 4.49K | 16.04K | S | Common Stock | -1.40M |
2024-03-04 | 2024-03-04 | Mussallem Michael A | Director | 20.53K | 13.31K | S | Common Stock | -1.15M |
2024-03-04 | 2024-03-04 | Mussallem Michael A | Director | 33.84K | 29.35K | M | Common Stock | 1.08M |
2024-02-29 | 2024-02-29 | Ullem Scott B. | CVP, Chief Financial Officer | 26.33K | 7.25K | M | Common Stock | 266.62K |
2024-02-29 | 2024-02-29 | Ullem Scott B. | CVP, Chief Financial Officer | 19.07K | 7.25K | S | Common Stock | -620.92K |
2024-02-26 | 2024-02-23 | Gallahue Kieran | Director | 70.28K | 7.06K | G | Common Stock | 0 |
2024-02-26 | 2024-02-23 | Gallahue Kieran | Director | 10.76K | 7.06K | M | Common Stock | 260.11K |
2024-02-26 | 2024-02-23 | Gallahue Kieran | Director | 3.70K | 7.06K | G | Common Stock | 0 |
2024-02-26 | 2024-02-23 | Gallahue Kieran | Director | 67.22K | 3.06K | S | Common Stock | -267.91K |
2024-02-21 | 2024-02-21 | Chopra Daveen | CVP, TMTT | 30.95K | 7K | M | Common Stock | 414.80K |
2024-02-21 | 2024-02-21 | Chopra Daveen | CVP, TMTT | 22.75K | 7K | S | Common Stock | -607.27K |
2024-02-21 | 2024-02-21 | Chopra Daveen | CVP, TMTT | 29.75K | 1.20K | S | Common Stock | -104.00K |
2024-02-20 | 2024-02-18 | Lippis Daniel J. | CVP, JAPAC | 17.21K | 188 | F | Common Stock | -16.19K |
2024-02-20 | 2024-02-17 | Lippis Daniel J. | CVP, JAPAC | 17.40K | 150 | F | Common Stock | -12.91K |
2024-02-20 | 2024-02-16 | Lippis Daniel J. | CVP, JAPAC | 17.55K | 207 | F | Common Stock | -17.81K |
2024-02-15 | 2024-02-13 | Szyman Catherine M. | CVP, Critical Care | 54.81K | 20K | M | Common Stock | 735K |
2024-02-15 | 2024-02-15 | Szyman Catherine M. | CVP, Critical Care | 34.81K | 27K | S | Common Stock | -2.31M |
2024-02-15 | 2024-02-15 | Szyman Catherine M. | CVP, Critical Care | 61.81K | 27K | M | Common Stock | 992.25K |
2024-02-15 | 2024-02-13 | Szyman Catherine M. | CVP, Critical Care | 34.81K | 20K | S | Common Stock | -1.73M |
2024-02-13 | 2024-02-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 50.50K | 11K | M | Common Stock | 404.25K |
2024-02-13 | 2024-02-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 50.03K | 470 | S | Common Stock | -40.58K |
2024-02-13 | 2024-02-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 10.53K | S | Common Stock | -903.57K |
2024-02-12 | 2024-02-12 | Sellers Robert W.A. | SVP, Corporate Controller | 25.30K | 12.21K | M | Common Stock | 448.72K |
2024-02-12 | 2024-02-12 | Sellers Robert W.A. | SVP, Corporate Controller | 13.09K | 12.21K | S | Common Stock | -1.06M |
2024-02-01 | 2024-02-01 | Ullem Scott B. | CVP, Chief Financial Officer | 19.25K | 7.25K | S | Common Stock | -567.99K |
2024-02-01 | 2024-02-01 | Ullem Scott B. | CVP, Chief Financial Officer | 26.50K | 7.25K | M | Common Stock | 266.62K |
2024-01-12 | 2024-01-12 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 49.50K | 10K | M | Common Stock | 367.50K |
2024-01-12 | 2024-01-12 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 10K | S | Common Stock | -756.70K |
2024-01-05 | 2024-01-05 | Mussallem Michael A | Director | 33.84K | 29.35K | M | Common Stock | 1.08M |
2024-01-05 | 2024-01-05 | Mussallem Michael A | Director | 4.49K | 26.85K | S | Common Stock | -1.96M |
2024-01-05 | 2024-01-05 | Mussallem Michael A | Director | 31.34K | 2.50K | S | Common Stock | -183.65K |
2023-12-29 | 2023-12-29 | Ullem Scott B. | CVP, Chief Financial Officer | 19.25K | 14.51K | S | Common Stock | -1.11M |
2023-12-29 | 2023-12-29 | Ullem Scott B. | CVP, Chief Financial Officer | 33.76K | 14.51K | M | Common Stock | 533.24K |
2023-12-15 | 2023-12-15 | Chopra Daveen | CVP, TMTT | 30.95K | 7K | M | Common Stock | 414.80K |
2023-12-15 | 2023-12-15 | Chopra Daveen | CVP, TMTT | 23.95K | 7K | S | Common Stock | -547.72K |
2023-12-13 | 2023-12-13 | Wood Larry L | Global President TAVR & Surg | 222.45K | 8.66K | M | Common Stock | 392.01K |
2023-12-13 | 2023-12-13 | Mussallem Michael A | Director | 4.49K | 13.72K | S | Common Stock | -1.03M |
2023-12-13 | 2023-12-13 | Mussallem Michael A | Director | 18.21K | 10.60K | S | Common Stock | -786.73K |
2023-12-13 | 2023-12-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 8K | S | Common Stock | -574.88K |
2023-12-13 | 2023-12-13 | Mussallem Michael A | Director | 32.01K | 1.83K | S | Common Stock | -138.43K |
2023-12-13 | 2023-12-13 | Mussallem Michael A | Director | 28.81K | 3.20K | S | Common Stock | -234.08K |
2023-12-13 | 2023-12-13 | Mussallem Michael A | Director | 33.84K | 29.35K | M | Common Stock | 1.08M |
2023-12-13 | 2023-12-13 | Wood Larry L | Global President TAVR & Surg | 213.79K | 8.66K | S | Common Stock | -622.16K |
2023-12-13 | 2023-12-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 47.50K | 8K | M | Common Stock | 294K |
2023-12-06 | 2023-12-06 | Chopra Daveen | CVP, TMTT | 27.45K | 3.50K | M | Common Stock | 207.40K |
2023-12-06 | 2023-12-06 | Chopra Daveen | CVP, TMTT | 23.95K | 3.50K | S | Common Stock | -245.01K |
2023-10-31 | 2023-10-31 | Ullem Scott B. | CVP, Chief Financial Officer | 26.50K | 7.25K | M | Common Stock | 266.62K |
2023-10-31 | 2023-10-31 | Ullem Scott B. | CVP, Chief Financial Officer | 19.25K | 7.25K | S | Common Stock | -454.57K |
2023-10-13 | 2023-10-13 | Wood Larry L | Global President TAVR & Surg | 218.94K | 3.51K | S | Common Stock | -244.33K |
2023-10-13 | 2023-10-13 | Wood Larry L | Global President TAVR & Surg | 222.45K | 8.66K | M | Common Stock | 392.10K |
2023-10-13 | 2023-10-13 | Wood Larry L | Global President TAVR & Surg | 213.79K | 5.15K | S | Common Stock | -361.86K |
2023-10-13 | 2023-10-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 3K | S | Common Stock | -210.75K |
2023-10-13 | 2023-10-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 44.50K | 5K | M | Common Stock | 183.75K |
2023-10-13 | 2023-10-13 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 42.50K | 2K | S | Common Stock | -139.16K |
2023-10-10 | 2023-10-10 | Szyman Catherine M. | CVP, Critical Care | 39.81K | 5K | M | Common Stock | 183.75K |
2023-10-10 | 2023-10-10 | Szyman Catherine M. | CVP, Critical Care | 34.81K | 5K | S | Common Stock | -363.40K |
2023-10-03 | 2023-10-03 | Chopra Daveen | CVP, TMTT | 32.45K | 8.50K | M | Common Stock | 503.68K |
2023-10-03 | 2023-10-03 | Chopra Daveen | CVP, TMTT | 23.95K | 8.50K | S | Common Stock | -595K |
2023-10-02 | 2023-10-02 | Mussallem Michael A | Director | 33.84K | 29.35K | M | Common Stock | 1.08M |
2023-10-02 | 2023-10-02 | Mussallem Michael A | Director | 4.49K | 29.35K | S | Common Stock | -2.02M |
2023-09-29 | 2023-09-29 | Ullem Scott B. | CVP, Chief Financial Officer | 19.25K | 7.25K | S | Common Stock | -504.53K |
2023-09-29 | 2023-09-29 | Ullem Scott B. | CVP, Chief Financial Officer | 26.50K | 7.25K | M | Common Stock | 266.62K |
2023-09-15 | 2023-09-14 | Markowitz Wayne | GM & SVP, Surgical | 7.26K | 7.26K | A | Common Stock | 0 |
2023-09-14 | 2023-09-14 | Wood Larry L | Global President TAVR & Surg | 213.79K | 8.66K | S | Common Stock | -637.62K |
2023-09-14 | 2023-09-14 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 44.00K | 4.50K | M | Common Stock | 165.38K |
2023-09-14 | 2023-09-14 | Wood Larry L | Global President TAVR & Surg | 222.45K | 8.66K | M | Common Stock | 392.10K |
2023-09-14 | 2023-09-14 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 4.50K | S | Common Stock | -331.69K |
2023-08-14 | 2023-08-14 | Wood Larry L | Global President TAVR & Surg | 213.79K | 6.42K | S | Common Stock | -509.19K |
2023-08-14 | 2023-08-14 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 44.00K | 4.50K | M | Common Stock | 165.38K |
2023-08-14 | 2023-08-14 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 4.50K | S | Common Stock | -356.85K |
2023-08-14 | 2023-08-14 | Wood Larry L | Global President TAVR & Surg | 220.21K | 6.42K | M | Common Stock | 290.72K |
2023-08-10 | 2023-08-10 | Stone Heisz Leslie | Director | 26.98K | 3.30K | S | Common Stock | -260.51K |
2023-08-09 | 2023-08-09 | Szyman Catherine M. | CVP, Critical Care | 39.81K | 5K | M | Common Stock | 183.75K |
2023-08-09 | 2023-08-09 | Szyman Catherine M. | CVP, Critical Care | 34.81K | 5K | S | Common Stock | -393.19K |
2023-08-01 | 2023-07-31 | Zovighian Bernard J | CEO | 47.11K | 2.56K | I | Common Stock | 213.74K |
2023-07-31 | 2023-07-31 | Ullem Scott B. | CVP, Chief Financial Officer | 26.50K | 7.25K | M | Common Stock | 266.62K |
2023-07-31 | 2023-07-31 | Ullem Scott B. | CVP, Chief Financial Officer | 19.25K | 7.25K | S | Common Stock | -611.96K |
2023-07-14 | 2023-07-14 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 39.50K | 3.50K | S | Common Stock | -325.28K |
2023-07-14 | 2023-07-14 | Bobo Donald E Jr | CVP,Strategy/Corp Development | 43.00K | 3.50K | M | Common Stock | 128.63K |
2023-07-14 | 2023-07-14 | Wood Larry L | Global President TAVR & Surg | 222.45K | 8.66K | M | Common Stock | 392.10K |